LEFT-VENTRICULAR FUNCTION AFTER ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX

被引：10

|

作者：

BEEN, M

MUIR, AL

DEBONO, DP

机构：

来源：

DRUGS | 1987年 / 33卷

关键词：

D O I：

10.2165/00003495-198700333-00034

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：191 / 197

页数：7

相关论文

共 50 条

[21] PREHOSPITAL ADMINISTRATION OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN ACUTE MYOCARDIAL-INFARCTION
CASTAIGNE, AD
DUVAL, AM
DUBOISRANDE, JL
HERVE, C
JAN, F
LOUVARD, Y
DRUGS, 1987, 33 : 231 - 234
[22] THE EFFECT OF THROMBOLYTIC THERAPY WITH ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON THE INDICATORS OF MYOCARDIAL SALVAGE
BUCHALTER, MB
BOURKE, JP
JENNINGS, K
ADAMS, PC
KENMURE, ACF
HAH, CW
REID, DS
DRUGS, 1987, 33 : 209 - 215
[23] AN INTERIM-REPORT OF THE EFFICACY AND SAFETY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC)
JOHNSON, ES
CREGEEN, RJ
DRUGS, 1987, 33 : 298 - 311
[24] INTRACORONARY STREPTOKINASE VERSUS INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
KASPAR, L
KARNIK, R
SEHNAL, E
ZAJICEK, P
ZIEGLER, B
SLANY, J
DRUGS, 1987, 33 : 179 - 182
[25] COMPARISON OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) AND INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
ANDERSON, J
ROTHBARD, R
HACKWORTHY, R
SORENSEN, S
FITZPATRICK, P
MARDER, V
THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 224 - 224
[26] IMPROVEMENT OF THE LEFT-VENTRICULAR FUNCTION AFTER FIBRINOLYSIS WITH INTRAVENOUS STREPTOKINASE
LIVAREK, B
CARRIE, D
DELAY, M
BERNADET, P
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1989, 38 (07): : 359 - 364
[27] EFFECT OF INTRAVENOUS STREPTOKINASE AS COMPARED WITH THAT OF TISSUE PLASMINOGEN-ACTIVATOR ON LEFT-VENTRICULAR FUNCTION AFTER 1ST MYOCARDIAL-INFARCTION
WHITE, HD
RIVERS, JT
MASLOWSKI, AH
ORMISTON, JA
TAKAYAMA, M
HART, HH
SHARPE, DN
WHITLOCK, RML
NORRIS, RM
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (13): : 817 - 821
[28] EFFICACY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX - EVIDENCE OF MYOCARDIAL-FUNCTION AND MORTALITY BENEFIT .3. DISCUSSION
HILLIS, WS
MEINERTZ, T
JOSEPH
SHERRY, S
BEEN, M
HACKWORTHY, RA
CHAMBERLAIN
KAMBARA
HUTTON
SORENSEN
DRUGS, 1987, 33 : 235 - 236
[29] ASSESSMENT OF LEFT-VENTRICULAR FUNCTION IN A RANDOMIZED STUDY OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION - PRELIMINARY-RESULTS OF THE EUROPEAN-MULTICENTER-STUDY (BELGIAN CENTERS)
TAEYMANS, Y
MATERNE, P
DRUGS, 1987, 33 : 216 - 220
[30] THE PROTECTIVE EFFECT OF ACYLATION ON THE STABILITY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX IN HUMAN-PLASMA
FEARS, R
FERRES, H
STANDRING, R
DRUGS, 1987, 33 : 57 - 63

← 1 2 3 4 5 →